Brnic Stjepan, Buric Bruno, Marcec Robert, Likic Robert
School of Medicine, University of Zagreb, Šalata 3, Zagreb, Croatia.
Clinical Hospital Centre Zagreb, Department of Internal Medicine, Unit for Clinical Pharmacology, Kišpatićeva ul. 12, Zagreb, Croatia.
Vaccine X. 2023 Sep 19;15:100391. doi: 10.1016/j.jvacx.2023.100391. eCollection 2023 Dec.
More than two years after SARS-CoV-2 emerged in Wuhan, China, COVID-19 has become one of the most severe pandemics in modern human history. Prior to the widespread availability of specific vaccines in 2021, public opinion surveys indicated significant vaccine hesitancy in 26 European countries.
Epidemiological data on COVID-19 morbidity and mortality for 26 European countries were collected in November 2021 and compared with the proportions of people willing to receive the SARS-CoV-2 vaccine according to public opinion surveys analysed in 2020. Correlations between various variables were calculated using the Pearson correlation test and visualized with the R programming language.
Paired Student's -test revealed no significant differences between survey results and actual vaccination rates (p = 0.9546), suggesting that the polls were good predictors. The percentage of people willing to receive the SARS-CoV-2 vaccine was significantly positively correlated with actual vaccination rates (R = 0.72, p = 0.00003) and significantly negatively correlated with the number of cumulative deaths per million people (R = -0.78, p = 0.0000024). However, there was no significant correlation with the number of cumulative cases per million people (R = -0.27, p = 0.18). These findings indicate that vaccines used in Europe were particularly effective at preventing severe COVID-19 and disease-related deaths, but did not necessarily provide strong protection against SARS-CoV-2 infection itself.
Encouraging widespread immunization through vaccination was crucial for rapidly improving the epidemiological situation in Europe.
在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)于中国武汉出现两年多后,冠状病毒病(COVID-19)已成为现代人类历史上最严重的大流行病之一。在2021年特定疫苗广泛供应之前,民意调查显示26个欧洲国家存在显著的疫苗犹豫现象。
收集了2021年11月26个欧洲国家COVID-19发病率和死亡率的流行病学数据,并与根据2020年分析的民意调查得出的愿意接种SARS-CoV-2疫苗的人群比例进行比较。使用Pearson相关检验计算各种变量之间的相关性,并用R编程语言进行可视化。
配对t检验显示调查结果与实际接种率之间无显著差异(p = 0.9546),表明民意调查是良好的预测指标。愿意接种SARS-CoV-2疫苗的人群比例与实际接种率显著正相关(R = 0.72,p = 0.00003),与每百万人口累计死亡数显著负相关(R = -0.78,p = 0.0000024)。然而,与每百万人口累计病例数无显著相关性(R = -0.27,p = 0.18)。这些发现表明,欧洲使用的疫苗在预防严重COVID-19和疾病相关死亡方面特别有效,但不一定能提供强大的针对SARS-CoV-2感染本身的保护。
通过接种疫苗鼓励广泛免疫对于迅速改善欧洲的流行病学状况至关重要。